Corrigendum to “Na(+)-dependent inactivation of vascular Na(+)/Ca(2+) exchanger responsible for reduced peripheral blood flow in neuropathic pain model” [Eur. J. Pharmacol. 910 (2021) 174448] (European Journal of Pharmacology (2021) 910, (S0014299921006026), (10.1016/j.ejphar.2021.174448))

H. Ishida, M. Yamaguchi, S. Y. Saito, T. Furukawa, J. L. Shannonhouse, Y. S. Kim, T. Ishikawa

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the acknowledgements were not complete in their original paper. Corrected Acknowledgements: We thank members of the Kim laboratory for helpful comments and discussion. This work was supported by grants for the research projects from University of Shizuoka and was also supported in part by Grants-in-Aid for Scientific Research (TI, 17H02175) from Japan Society for the Promotion of Science JSPS KAKENHI Grant. This work was also supported by National Institutes of Health Grant (R01DE026677 to Y.K.), UTHSA startup funds, a STAR Award from University of Texas system (Y.K), and a Craniofacial Oral-biology Student Training in Academic Research (COSTAR) National Institutes of Health Grant T32DE014318. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number176495
JournalEuropean Journal of Pharmacology
Volume970
DOIs
StatePublished - May 5 2024

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Corrigendum to “Na(+)-dependent inactivation of vascular Na(+)/Ca(2+) exchanger responsible for reduced peripheral blood flow in neuropathic pain model” [Eur. J. Pharmacol. 910 (2021) 174448] (European Journal of Pharmacology (2021) 910, (S0014299921006026), (10.1016/j.ejphar.2021.174448))'. Together they form a unique fingerprint.

Cite this